Y Cadroy

2.0k total citations
52 papers, 1.5k citations indexed

About

Y Cadroy is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Y Cadroy has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 21 papers in Cardiology and Cardiovascular Medicine and 17 papers in Internal Medicine. Recurrent topics in Y Cadroy's work include Blood Coagulation and Thrombosis Mechanisms (25 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Y Cadroy is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (25 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Y Cadroy collaborates with scholars based in France, United States and Norway. Y Cadroy's co-authors include B Boneu, Kjell S. Sakaríassen, Stephen R. Hanson, Claire Thalamas, Piérre Siè, Jean-Pierre Bossavy, D. Dupouy, Luc Sagnard, Laurence A. Harker and AB Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Y Cadroy

52 papers receiving 1.4k citations

Peers

Countries citing papers authored by Y Cadroy

Since Specialization

Citations

This map shows the geographic impact of Y Cadroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Cadroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Cadroy more than expected).

Fields of papers citing papers by Y Cadroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Cadroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Cadroy. The network helps show where Y Cadroy may publish in the future.

Co-authorship network of co-authors of Y Cadroy

This figure shows the co-authorship network connecting the top 25 collaborators of Y Cadroy. A scholar is included among the top collaborators of Y Cadroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Cadroy. Y Cadroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic value of body-mass index on mortality in older adults with dementia living in nursing homes 2015 ·Clinical Nutrition ·Philipe de Souto Barreto, Y Cadroy, Eirini Kelaiditi, Bruno Vellas, Yves Rolland	19
2	Efficacy and safety of fondaparinux in patients with acute coronary syndromes 2007 ·Expert Review of Cardiovascular Therapy ·Jean‐Pierre Bassand, (unknown), Y Cadroy	6
3	Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers 2005 ·Thrombosis Research ·Y Cadroy, Claire Thalamas, Kjell S. Sakaríassen, B Boneu	8
4	Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers 2002 ·Journal of Applied Physiology ·Y Cadroy, Fabien Pillard, Kjell S. Sakaríassen, Claire Thalamas, B Boneu, Daniel Rivière	64
5	The Expression of Tissue Factor and Tissue Factor Pathway Inhibitor in Aortic Smooth Muscle Cells Is Up-regulated in Synthetic Compared to Contractile Phenotype 2002 ·Thrombosis and Haemostasis ·(unknown), (unknown), D. Dupouy, Anne-Dominique Terrisse, (unknown), Y Cadroy, B Boneu, Piérre Siè	8
6	Methods and Models to Evaluate Shear-Dependent and Surface Reactivity-Dependent Antithrombotic Efficacy 2001 ·Thrombosis Research ·Kjell S. Sakaríassen, Stephen R. Hanson, Y Cadroy	49
7	Nonfractionated Heparin Fails to Inhibit Arterial Thrombosis in a Human Ex Vivo Thrombosis Model 1999 ·Annals of Vascular Surgery ·Jean-Pierre Bossavy, Y Cadroy, Kjell S. Sakaríassen, B Boneu, A Barret	7
8	A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans 1998 ·Blood ·Jean-Pierre Bossavy, Claire Thalamas, Luc Sagnard, A Barret, Kjell S. Sakaríassen, B Boneu, Y Cadroy	61
9	A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans 1998 ·Blood ·Jean-Pierre Bossavy, Claire Thalamas, Luc Sagnard, A Barret, Kjell S. Sakaríassen, B Boneu, Y Cadroy	1
10	Association maladie de Willebrand acquise - gammapathie monoclonale — angiodysplasie du grêle: une indication rare des immunoglobulines intraveineuses à forte dose 1996 ·La Revue de Médecine Interne ·L. Sailler, (unknown), Y Cadroy, (unknown), Piérre Siè, Claudine Mazurier, (unknown), (unknown)	8
11	A Comparative Study of the Anticoagulant and Antithrombotic Effects of Unfractionated Heparin and a Low Molecular Weight Heparin (Fraxiparine®) in an Experimental Model of Human Venous Thrombosis 1995 ·Thrombosis and Haemostasis ·Armelle Diquélou, D. Dupouy, R Cariou, Kjell S. Sakaríassen, B Boneu, Y Cadroy	18
12	Frequency of a defective response to activated protein C in patients with a history of venous thrombosis [letter; comment] 1994 ·Blood ·Y Cadroy, Piérre Siè, B Boneu	30
13	Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates. 1993 ·Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Y Cadroy, Stephen R. Hanson, Laurence A. Harker	10
14	Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates. 1992 ·PubMed ·(unknown), Almasa Bass, Y Cadroy, (unknown), Harker La, Hanson	12
15	Comparison of the fibrinolytic response to 10 minutes venous occlusion in males with and without antecedent of deep vein thrombosis 1991 ·Thrombosis Research ·Y Cadroy, (unknown), Piérre Siè, B Boneu	2
16	Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons. 1991 ·Proceedings of the National Academy of Sciences ·Y Cadroy, John M. Maraganore, Stephen R. Hanson, Laurence A. Harker	22
17	Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model 1990 ·Blood ·Y Cadroy, (unknown)	2
18	RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. 1989 ·Journal of Clinical Investigation ·Y Cadroy, R A Houghten, Stephen R. Hanson	36
19	Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. 1989 ·PubMed ·Y Cadroy, T. A. Horbett, Stephen R. Hanson	59
20	Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit 1988 ·Seminars in Thrombosis and Hemostasis ·B Boneu, C. Caranobe, Y Cadroy, Frédérique Dol, A.M. Gabaig, D. Dupouy, Piérre Siè	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact